Inactive Instrument

Other languages Zynerba Pharmaceuticals, Inc.

Equities

ZYNE

US98986X1090

Other languages

Unlock all the news: Be the first to know and act before the market!

Zynerba Pharmaceuticals, Inc. acquired Epygenix Therapeutics, Inc for $680 million.	04-29
Harmony Biosciences Holdings Completes Acquisition of Zynerba Pharmaceuticals	23-10-11
Harmony Biosciences Holdings, Inc. completed the acquisition of Zynerba Pharmaceuticals, Inc..	23-10-09
Harmony Biosciences Says its Xylophone Acquisition Unit Extends Tender Offer for Zynerba Pharmaceuticals to Oct. 10	23-09-27
Sector Update: Health Care Stocks Higher Late Afternoon	23-08-14
Sector Update: Health Care Stocks Higher on Monday Afternoon	23-08-14
Top Midday Gainers	23-08-14
Zynerba Pharmaceuticals Shares Soar on Harmony Biosciences Acquisition Deal	23-08-14
Sector Update: Health Care Stocks Edge Higher Premarket Monday	23-08-14
Sector Update: Health Care	23-08-14
Harmony Biosciences Agrees to Acquire Zynerba Pharmaceuticals	23-08-14
Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.	23-08-14
Zynerba Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Zynerba Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Zynerba Pharmaceuticals, Inc. Presents Data on Zygel at the 55th Gatlinburg Conference	23-04-12
Zynerba Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28
Zynerba Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-28
Optimism Ahead of Consumer Confidence Report Lifts Exchange-Traded Funds, Equity Futures Pre-Bell Wednesday	22-12-21
Zynerba Delays Reporting of Top-Line Results From Phase 3 Trial of Zygel Drug in Fragile X syndrome	22-12-21
Zynerba Pharmaceuticals Announces Update on Reconnect, the Pivotal Phase 3 Trial of Zygel™ in Fragile X Syndrome	22-12-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zynerba Pharmaceuticals, Inc.

Equities

ZYNE

US98986X1090

Other languages

Filters